CB 1922

Drug Profile

CB 1922

Alternative Names: CB1922; SpirH; Synthetic steroidal lactone - Canopus BioPharma

Latest Information Update: 28 Jul 2015

Price : $50

At a glance

  • Originator Canopus BioPharma
  • Class Antiretrovirals; Lactones
  • Mechanism of Action Aldosterone antagonists; HIV replication inhibitors; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 29 Nov 2007 Synthetic steroidal lactone is available for licensing in South Africa (http://www.canopusbiopharma.com)
  • 10 Oct 2007 Phase-II clinical trials in HIV infections treatment in South Africa (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top